Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors
Gastric Cancer · 2025
DOI: 10.1007/s10120-025-01633-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastric Cancer, 2025. Verfasst von Seita Hagihara und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Ja…. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Gastrointestinal Stromal Tumors, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Medtronic Japan.
Abstract (Originalsprache)
BACKGROUND: Boron neutron capture therapy selectively delivers the boron isotope 10B to tumors, where neutron irradiation induces a nuclear reaction that generates particle radiation, eradicating cancer cells. Imatinib and other drug therapies remain standard treatments for recurrent and unresectable gastrointestinal stromal tumors; however, their efficacy is limited by drug resistance. Therefore, developing novel therapeutic strategies for unresectable gastrointestinal stromal tumors is essential. This study aimed to investigate the therapeutic potential of boron neutron capture therapy for recurrent and unresectable gastrointestinal stromal tumors. METHODS: The GIST-T1 cell line and its imatinib-resistant variant (GIST-T1/IM-R) were utilized to assess boronophenylalanine uptake and evaluate boron neutron capture therapy efficacy in both in vitro and in vivo models. RESULTS: Boronophenylalanine was substantially incorporated into GIST-T1 and GIST-T1/IM-R cells. Boron neutron capture therapy significantly reduced survival fractions in both cell lines compared to neutron irradiation alone. In the GIST-T1 mouse model, high boronophenylalanine uptake was observed 3 h post-administration, resulting in significant tumor growth suppression following boron neutron capture therapy. Elevated expression of cleaved PARP, Caspase-3, Caspase-8, and γH2AX significantly increased in GIST-T1 tumors post-boron neutron capture therapy. CONCLUSIONS: The results indicate that boron neutron capture therapy suppresses tumor growth by inducing extrinsic apoptosis through severe DNA damage. This study suggests that boron neutron capture therapy is a promising alternative treatment for gastrointestinal stromal tumors, particularly for cases exhibiting resistance to conventional therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
- Department of General and Gastroenterological Surgery, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan. jun.arima@ompu.ac.jp.
- Department of Particle Radiation Oncology, Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2 Asashiro- Nishi, Kumatori-Cho, Sennan-Gun, Osaka, 590-0494, Japan.
- Center for Medical Research and Development, Division of Translational Research, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-Machi, Takatsuki, Osaka, 569-8686, Japan.
ORCID-Profile: Jun Arima
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Medtronic Japan
Zitieren
APA
Hagihara, S., Arima, J., Ueda, Y., Inomata, Y., Shima, T., Suzuki, M., Lee, S. W., & Taniguchi, K. (2025). Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors. Gastric Cancer. https://doi.org/10.1007/s10120-025-01633-7
Vancouver
Hagihara S, Arima J, Ueda Y, Inomata Y, Shima T, Suzuki M, et al. Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors. Gastric Cancer. 2025. doi:10.1007/s10120-025-01633-7
BibTeX
@article{Hagihara2025,
author = {Hagihara, Seita and Arima, Jun and Ueda, Yasuhiko and Inomata, Yosuke and Shima, Takafumi and Suzuki, Minoru and Lee, Sang-Woong and Taniguchi, Kohei},
title = {Evaluating boron neutron capture therapy as a potential treatment for unresectable gastrointestinal stromal tumors},
journal = {Gastric Cancer},
year = {2025},
doi = {10.1007/s10120-025-01633-7}
}
EUVIMED